Cognito Therapeutics is a leader in non-invasive neuromodulation aimed at treating neurodegenerative diseases and enhancing cognitive performance. The company has conducted multiple clinical studies showing promise in slowing or stopping cognitive decline and brain volume loss in Alzheimer's disease, with FDA Breakthrough Device Designation. Founded on groundbreaking optogenetics research by MIT professors, Cognito is poised to begin pivotal trials in 2022.
Cognito Therapeutics is a venture-backed company translating scientific findings from MIT into therapeutic approaches for brain health. They are seeking a talented Software Developer to join their team and contribute to the development of innovative software solutions for improving brain health and well-being. The role involves designing, developing, and maintaining high-quality software solutions, collaborating with cross-functional teams, and staying current with industry trends.
Cognito Therapeutics is a leader in non-invasive neuromodulation aimed at treating neurodegenerative diseases and enhancing cognitive performance. The company has conducted multiple clinical studies showing promise in slowing or stopping cognitive decline and brain volume loss in Alzheimer's disease, with FDA Breakthrough Device Designation. Founded on groundbreaking optogenetics research by MIT professors, Cognito is poised to begin pivotal trials in 2022.
Peterson Technologies